We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$261M
AUM Growth
+$17.5M
Cap. Flow
+$13.1M
Cap. Flow %
5.04%
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
2
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$9.11M
2
FAZE
FaZe Holdings Inc. Common Stock
FAZE
+$2.68M
3
NVO
Novo Nordisk
NVO
+$2.07M
4
IDR icon
Idaho Strategic Resources
IDR
+$292K

Top Sells

Rank Stock Value
1
MSAC
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
+$1.01M
2
MSACW
Medicus Sciences Acquisition Corp. Warrant
MSACW
+$1K

Sector Composition

Rank Sector Weight
1 Healthcare 95.87%
2 Consumer Staples 3.07%
3 Communication Services 0.55%
4 Materials 0.51%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTA icon
1
Establishment Labs
ESTA
$2.73B
$216M 83%
3,192,485
– –
NVO
2
Novo Nordisk
NVO
$228B
$9.41M 3.61%
118,200
+29,200
+33% +$2.07M
CPRX
3
DELISTED
Catalyst Pharmaceutical
CPRX
$9.34M 3.58%
563,392
– –
LLY icon
4
Eli Lilly
LLY
$1.08T
$9.27M 3.56%
+27,000
New +$9.11M
CELH icon
5
Celsius Holdings
CELH
$7.47B
$8M 3.07%
258,114
– –
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.53M 2.12%
50,673
– –
FAZE
7
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$1.44M 0.55%
+3,126,319
New +$2.68M
IDR icon
8
Idaho Strategic Resources
IDR
$449M
$1.32M 0.51%
271,697
+54,546
+25% +$292K
MSACW
9
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
– –
-11,110
Closed -$1K
MSAC
10
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
– –
-100,000
Closed -$1.01M

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, JW Asset Management held 10 positions worth $261M, up 7.2% from $243M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

JW Asset Management deployed $13.1M of net new capital in Q1 2023, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Eli Lilly: 27,000 shares worth $9.27M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Consumer Staples and Communication Services.

On the sell side, the most notable exit was Medicus Sciences Acquisition Corp. Class A Ordinary Share, an estimated $1.01M sold.

  • JW Asset Management's largest Q1 2023 buy was Eli Lilly: 27,000 shares worth $9.27M.
  • JW Asset Management added most to Novo Nordisk in Q1 2023, an estimated $2.07M increase.
  • JW Asset Management fully exited Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q1 2023, selling an estimated $1.01M.
  • JW Asset Management's ten largest holdings make up 100% of its $261M portfolio in Q1 2023.
  • JW Asset Management opened 2 new positions and closed 2 in Q1 2023.
  • JW Asset Management's portfolio value rose 7.2% quarter-over-quarter to $261M.

Based on JW Asset Management's 13F filing for Q1 2023, filed 5 May 2023.